| Date | Title | Description | Source |
| 13.09.2022 | Novome gets $43.5M boost for its engineered microbiome thera... | Novome Biotechnologies — a South San Francisco-based biotech focused on genetically engineered micro... | medcitynew... |
| 19.04.2022 | Free Market Health Secures $13.5M for Advance Specialty Phar... | What You Should Know:
Free Market Health, a Pittsburgh-based healthcare technology company transfor... | hitconsult... |
| 11.01.2022 | Transcarent Raises $200M to Expand Care Platform for Self-In... | What You Should Know:
– Transcarent, a new and different health and care experience company for emp... | hitconsult... |
| 03.03.2021 | DispatchHealth Management, LLC announced that it has receive... | On March 3, 2021, DispatchHealth Management, LLC closed the transaction. The transaction was led by ... | marketscre... |
| 19.02.2021 | Alta Partners Closes NextGen Fund III, at $275M | Alta Partners, a San Francisco, CA and Denver, CO-based early-stage healthcare venture capital firm,... | finsmes.co... |
| 24.06.2020 | Denver on-demand health care startup closes $136M Series C | Denver's DispatchHealth, a provider of tech-enabled in-home health care, announced the closing of $1... | bizjournal... |
| 23.06.2020 | DispatchHealth Raises $135.8M to Expand On-Demand In-Home Ca... | What You Should Know
– Today DispatchHealth announced the closing of $135.8 million growth capital ... | hitconsult... |
| 07.05.2019 | DispatchHealth Nabs $33M to Expand On-Demand Healthcare Mode... | DispatchHealth (formerly known as True North Health Navigation), a Denver, CO-based provider of on-d... | hitconsult... |
| 26.08.2018 | NEA Leads $165M Funding for Paladina Health | Paladina Health, an innovative physician-access model of health care that improves patient care and ... | citybizlis... |
| 26.08.2018 | Oak HC/FT Joins $165M Funding for Paladina Health | Paladina Health, an innovative physician-access model of health care that improves patient care and ... | citybizlis... |
| 13.06.2018 | Term Sheet — Wednesday, June 13 | A WILD RIDE
Reports surfaced yesterday that Bird is raising even more capital. This time, the elect... | fortune.co... |
| 24.09.2017 | Questa Capital Leads $30.8M Funding for DispatchHealth | DispatchHealth, a Denver-based healthcare company offering on-demand, on-site healthcare services de... | citybizlis... |
| 15.05.2017 | Alta Partners desembarca en España y lanza el fondo Alta Lif... | 15/05/2017
ALTA PARTNERS DESEMBARCA EN ESPAÑA Y LANZA EL FONDO ALTA LIFE SCIENCES SPAIN (ALTA LS).
... | webcapital... |
| 28.01.2017 | El inversor americano Alta Partners desembarca en Barcelona ... | 28/01/2017
EL GRUPO INVERSOR AMERICANO ALTA PARTNERS DESEMBARCA EN BARCELONA Y LANZA UN FONDO DE CI... | webcapital... |
| 30.09.2014 | Allakos Raises $10M in Funding | Allakos, a San Francisco Bay Area-based biotechnology company, raised an additional $10m in funding.... | finsmes.co... |
| 19.07.2013 | What’s special about the 3 biotechs in the top 10 for Q2 ven... | But let’s look a little more closely at the those three biotechnology companies and what they say ab... | medcitynew... |
| 08.05.2013 | Lumena Pharmaceuticals Secures $23M in Series A Financing | Lumena Pharmaceuticals, a San Diego, CA-based developer of oral therapeutics for rare liver diseases... | finsmes.co... |
| 25.04.2013 | Esperion Therapeutics Completes $33M Financing | Esperion Therapeutics, Inc., a Plymouth, MI-based clinical stage biopharmaceutical company, complete... | finsmes.co... |
| 25.04.2013 | Esperion Therapeutics Raises $33M to Further Clinical Trials | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
The Ann Arbor-based biotech compan... | xconomy.co... |
| 17.12.2012 | Allakos Completes $32M Series A Financing | Allakos Inc., a San Francisco Bay Area-based biotechnology company, has completed a $32m Series A fi... | finsmes.co... |
| 28.10.2012 | ZS Pharma Closes $46M Financing | ZS Pharma Inc., a Fort Worth, Texas-based specialty pharmaceutical company, has closed a $46m financ... | finsmes.co... |
| 30.04.2010 | ATS Medical backers stand to gain from Medtronic buyout | By Thomas Lee
ATS Medical Inc. (NSDQ:ATSI) stock has been a dog for quite a while, never rising abo... | massdevice... |
| 29.04.2010 | Select investors could make a killing on Medtronic/ATS Medic... | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis... | medcitynew... |
| 30.07.2009 | Pain treatment maker TorreyPines saved by Raptor merger | TorreyPines Therapeutics, maker of pain management medication, has skirted failure through a $1.4 mi... | venturebea... |
| 08.04.2009 | Aerovance inhales $38M for asthma drugs | Aerovance, developer of asthma medications, just brought in $38 million in a post-recapitalized thir... | venturebea... |
| 13.01.2009 | Sanarus raises $3M to battle breast cancer | Sanarus Medical, maker of a device used to diagnose and treat breast cancer, brought in $3 million i... | venturebea... |
| 08.01.2009 | Plexxikon teams up with Roche, eyes $335M to fight kidney di... | Pharmaceutical company Plexxikon has joined forces with health care giant Roche for at least $60 mil... | venturebea... |
| 08.01.2009 | Dogster still has its bite despite the downturn | Dogster, the social network for dogs and their owners, just converted $425,000 in bridge funds into ... | venturebea... |
| 07.01.2009 | Intradigm closes $21.4M for cancer therapeutics | Biotech firm Intradigm has tacked an additional $2.9 million onto its second round of funding, bring... | venturebea... |
| 16.12.2008 | IPO market freezes out two more health care startups | Poor market conditions have dashed the IPO hopes of two more health care companies — clinical data p... | venturebea... |
| 20.11.2008 | Arete nabs $16.7M more to treat metabolic disorders | Biotech company Arete Therapeutics brought in $16.7 million in the final tranche of a first round of... | venturebea... |
| 17.11.2008 | Cancer drug developer ChemoCentryx cancels IPO | Mountain View, Calif.-based biotech firm ChemoCentryx announced that it withdrew its filing to go pu... | venturebea... |
| 04.11.2008 | Oracle scoops up Tacit’s intellectual property | Oracle announced yesterday that it has purchased intellectual property rights from Tacit Software fo... | venturebea... |
| 24.10.2008 | Phenomix cancels IPO, finds new lab partner | Biopharmaceuticals company Phenomix withdrew its filing to go public yesterday and right away announ... | venturebea... |
| 03.10.2008 | Intradigm lands $18.5M to advance oncology treatment | Intradigm, a biotech company that develops RNA interference treatments for cancer, announced today t... | venturebea... |
| 15.08.2008 | Xelerated raises $13 million for fast networking chips | Xelerated, a maker of networking chip sets for carriers, has raised a $13 million round from its exi... | venturebea... |
| 20.11.2007 | Agami raising $50 million — for yet another storage company... | Agami, a Silicon Valley storage company with high-profile venture backing, is doing what any self-re... | venturebea... |
| 13.08.2007 | Life sciences briefing: Monday, Aug. 13, 2007 | (UPDATED: See below.)
Featured companies: FoldRx Pharmaceuticals, Ophthotech, Pevion Biotech, Resto... | venturebea... |
| 12.07.2007 | Agensys pulls in $41M for cancer drugs | Santa Monica, Calif.-based Agensys, a biotech focused on new cancer drugs, raised $41 million in a f... | venturebea... |
| 29.06.2007 | Paracor raises $44M for heart-failure device that restrains ... | (UPDATED: See below.) Paracor Medical, a Sunnyvale, Calif., startup developing a mesh restraint desi... | venturebea... |
| 26.06.2007 | Ceregene: Catching an updraft in gene therapy | (UPDATED: See below.)
Ceregene, a San Diego biotech at work on a gene therapy for Parkinson’s disea... | venturebea... |
| 23.05.2007 | Arete raises $35M for cardiovascular treatments | Arete Therapeutics, a Hayward, Calif., developer of biotech cardiovascular treatments, raised a $35 ... | venturebea... |
| 08.05.2007 | Cardiovascular biotech Portola Pharmaceuticals raises $70M, ... | Portola Pharmaceuticals, a South San Francisco, Calif., biotech aiming to develop treatments for blo... | venturebea... |
| 09.10.2006 | Alta Partners has raised $500M fund | Alta Partners has raised $500 million for its eighth venture fund, according to VentureWire (sub req... | venturebea... |
| - | Select investors could make a killing on Medtronic/ATS Medic... | ATS Medical Inc. (NASDAQ:ATSI) stock has been a dog for quite a while, never rising above $5 a share... | medcitynew... |
| - | What’s special about the 3 biotechs in the top 10 for Q2 ven... | Cellular engineering, precision medicine, and using G protein-coupled receptors to treat heart failu... | medcitynew... |
